Cargando…

Hepatitis C Seroprevalence and Associated Risk Factors, Anyang, China

Hepatitis C virus screening was conducted among 8,226 residents 25–65 years of age in 4 counties of China; virus prevalence was 0.9%. A subsequent case–control study indicated blood transfusion (odds ratio [OR] 4.55), esophageal balloon examination (OR 3.78), and intravenous injection (OR 5.83) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fangfang, Chen, Ke, He, Zhonghu, Ning, Tao, Pan, Yaqi, Cai, Hong, Ke, Yang
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857224/
https://www.ncbi.nlm.nih.gov/pubmed/19891874
http://dx.doi.org/10.3201/eid1511.0900263
_version_ 1782180296309866496
author Liu, Fangfang
Chen, Ke
He, Zhonghu
Ning, Tao
Pan, Yaqi
Cai, Hong
Ke, Yang
author_facet Liu, Fangfang
Chen, Ke
He, Zhonghu
Ning, Tao
Pan, Yaqi
Cai, Hong
Ke, Yang
author_sort Liu, Fangfang
collection PubMed
description Hepatitis C virus screening was conducted among 8,226 residents 25–65 years of age in 4 counties of China; virus prevalence was 0.9%. A subsequent case–control study indicated blood transfusion (odds ratio [OR] 4.55), esophageal balloon examination (OR 3.78), and intravenous injection (OR 5.83) were associated with infection.
format Text
id pubmed-2857224
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-28572242010-05-06 Hepatitis C Seroprevalence and Associated Risk Factors, Anyang, China Liu, Fangfang Chen, Ke He, Zhonghu Ning, Tao Pan, Yaqi Cai, Hong Ke, Yang Emerg Infect Dis Dispatch Hepatitis C virus screening was conducted among 8,226 residents 25–65 years of age in 4 counties of China; virus prevalence was 0.9%. A subsequent case–control study indicated blood transfusion (odds ratio [OR] 4.55), esophageal balloon examination (OR 3.78), and intravenous injection (OR 5.83) were associated with infection. Centers for Disease Control and Prevention 2009-11 /pmc/articles/PMC2857224/ /pubmed/19891874 http://dx.doi.org/10.3201/eid1511.0900263 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Liu, Fangfang
Chen, Ke
He, Zhonghu
Ning, Tao
Pan, Yaqi
Cai, Hong
Ke, Yang
Hepatitis C Seroprevalence and Associated Risk Factors, Anyang, China
title Hepatitis C Seroprevalence and Associated Risk Factors, Anyang, China
title_full Hepatitis C Seroprevalence and Associated Risk Factors, Anyang, China
title_fullStr Hepatitis C Seroprevalence and Associated Risk Factors, Anyang, China
title_full_unstemmed Hepatitis C Seroprevalence and Associated Risk Factors, Anyang, China
title_short Hepatitis C Seroprevalence and Associated Risk Factors, Anyang, China
title_sort hepatitis c seroprevalence and associated risk factors, anyang, china
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857224/
https://www.ncbi.nlm.nih.gov/pubmed/19891874
http://dx.doi.org/10.3201/eid1511.0900263
work_keys_str_mv AT liufangfang hepatitiscseroprevalenceandassociatedriskfactorsanyangchina
AT chenke hepatitiscseroprevalenceandassociatedriskfactorsanyangchina
AT hezhonghu hepatitiscseroprevalenceandassociatedriskfactorsanyangchina
AT ningtao hepatitiscseroprevalenceandassociatedriskfactorsanyangchina
AT panyaqi hepatitiscseroprevalenceandassociatedriskfactorsanyangchina
AT caihong hepatitiscseroprevalenceandassociatedriskfactorsanyangchina
AT keyang hepatitiscseroprevalenceandassociatedriskfactorsanyangchina